Genetic correlation and causality between smoking and 42 neuropsychiatric and gastrointestinal diseases

Jiayi Xiong,zheng Wang,Yuanfeng Huang,Shiyu Zhang,Guang Yang,Jiaqi Yang,Shuo Gao,Tianyang Wang,Jinchen Li,Guihu Zhao,Bin Li
DOI: https://doi.org/10.1101/2024.05.09.24307140
2024-05-10
Abstract:Background Previous investigations have elucidated epidemiological associations linking smoking to neuropsychiatric and gastrointestinal diseases, yet the underlying causal relationships remain enigmatic. To shed light on this matter, we undertook a Mendelian randomisation(MR) study with the aim of gauging the potential causal association between smoking and the susceptibility to neuropsychiatric and gastrointestinal tract diseases. Methods We meticulously collected and preprocessed genome-wide association study (GWAS) data encompassing smoking (280,508 cases and 180,558 controls) as well as neuropsychiatric and gastrointestinal phenotypes (n = 6,681 to 87,3341). To investigate the genetic correlation between smoking and diseases, we employed linkage disequilibrium score regression. We further applied multi-trait analysis of GWAS to identify the shared risk single-nucleotide polymorphisms (SNPs) implicated in both smoking and diseases. Pleiotropic genes were annotated by enrichment analysis. Subsequently, bidirectional MR analysis was performed to infer causality. Results Our findings, supported by robust evidence derived from an expansive sample size, demonstrate that smoking exerts a causal influence on merely six of these diseases, while no disease was found to causally impact smoking. Intriguingly, we discovered 513 pleiotropic genes enriched in pathways such as the regulation of growth and synapses, suggesting a potential shared genetic basis between smoking and these diseases, leading to aberrant neural development. Remarkably, among the 42 diseases scrutinized, a significant genetic correlation was exclusively observed with gastroesophageal reflux disease (GRED). Furthermore, we identified risk SNPs shared by smoking and GRED. Conclusions This study revealed the shared genetic basis and causal effects connecting smoking to neuropsychiatric and gastrointestinal diseases, thereby providing novel etiological insights into the role of smoking in these diseases.
What problem does this paper attempt to address?
The paper investigates the genetic correlation and causal relationship between smoking and 42 neuro-psychiatric and gastrointestinal diseases using Mendelian randomization. The study finds causal associations between smoking and 6 diseases, but no causal impact of any disease on smoking. Specifically, there is a significant negative genetic correlation between smoking and gastroesophageal reflux disease (GERD), suggesting that certain smoking-related genetic factors may have a protective effect on GERD. Additionally, the study identifies 513 genes that may play a joint role in smoking and these diseases, enriched in pathways such as growth regulation and synapses.